| 摘要 |
<p>The invention relates to a pharmaceutical composition for treating dependency in human beings, including the following two active principles: cyproheptadine, which is selected to be a compound having an antagonistic activity against the 5-HT2 serotonin receptors; and a compound having an antagonistic activity against the alpha-1 noradrenergic receptors, selected from among prazosin, alfuzosin, terazosin, tamsulosin, silodosin and doxazosin.</p> |
